Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Parkin Protein

Dieses Recombinant Parkin-Protein wird in Escherichia coli (E. coli) produziert.
Produktnummer ABIN2746992

Kurzübersicht für Parkin Protein (ABIN2746992)

Target

Alle Parkin (PARK2) Proteine anzeigen
Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))

Protein-Typ

Recombinant

Spezies

  • 9
  • 2
  • 1
Human

Quelle

  • 6
  • 2
  • 2
  • 1
  • 1
Escherichia coli (E. coli)

Applikation

Western Blotting (WB), Positive Control (PC)
  • Verwendungszweck

    Purified Protein in ready-to-use SDS sample buffer.

    Aufreinigung

    Purified Protein
  • Möchten Sie weitere Optionen für dieses Protein ?

    !
    Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!
    Produkt
    Expressionssystem
    Konjugat
    Origin
    Preis ab
    Expressionssystem HEK-293 Cells
    Konjugat His tag
    Origin Human
    Preis ab 13.711,36 €
    Expressionssystem Cell-free protein synthesis (CFPS)
    Konjugat Strep Tag
    Origin Human
    Preis ab 20.480,57 €

    Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen

  • Applikationshinweise

    The sample is in ready-to-use buffer for application in SDS-PAGE and Western blotting.

    Kommentare

    Synonyms: PARK2, E3 ubiquitin-protein ligase parkin antibody, PRKN

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    For 5 applications, volume varies from 100-200 μL in reduced SDS-PAGE sample buffer.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    -20 °C for long term storage
  • Target

    Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))

    Andere Bezeichnung

    Parkin

    Hintergrund

    Parkin is a zinc-finger protein with an amino-terminal ubiquitin domain and a carboxy-terminal RING-box. The encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Phosphorylation of Parkin at Ser101 has a regulatory role on its E3 ubiquitin ligase activity. Mutations in this gene cause Parkinson disease and autosomal recessive juvenile Parkinson (AR-JP) disease which is characterized by the progressive loss of dopaminergic neurons and the presence of Lewy bodies in the substania nigra. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Parkin is an ubiquitin-protein ligase expresses in many tissues such as brain, testis, skeletal muscle and heart. In humans, Parkin is highly expressed in the basal ganglia, midbrain, cerebellum and cerebral cortex. Parkin expression is also high in the brainstem of mice, with the majority of immuno positive cells being neurons. It is a RING-type E3 ubiquitin-protein ligase that facilitates the ubiquitination of misfolded proteins by participating in the removal and/or detoxification of abnormally folded or damaged protein. It also plays a role in controlling neurotransmitter trafficking at the presynaptic terminal and in calcium-dependent exocytosis. Parkin is an E3 ubiquitin ligase used to reduce intra neuronal amyloid-β (Aβ) levels and enhance autophagic clearance of Aβ-induced defects in AD. Parkin-mediated clearance of ubiquitinated Aβ act in parallel with autophagy to clear molecular debris and defective mitochondria and restore neurotransmitter balance.The human Parkin gene maps to chromosome 6q25.2-q27 and encodes a 465 amino acid protein.

    Molekulargewicht

    56 kDa

    UniProt

    O60260

    Pathways

    Autophagie, Ubiquitin Proteasome Pathway
Sie sind hier:
Chat with us!